Cva Family Office, LLC Beam Therapeutics Inc. Transaction History
Cva Family Office, LLC
- $606 Million
- Q3 2024
A detailed history of Cva Family Office, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 22 shares of BEAM stock, worth $504. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 22
-0.0%
Holding current value
$504
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
230Shares Held
70.7MCall Options Held
283KPut Options Held
233K-
Farallon Capital Management LLC San Francisco, CA7.91MShares$181 Million0.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$181 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$175 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$150 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL5.44MShares$125 Million74.72% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.61B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...